key: cord-0287581-32lrk28s
authors: Cedro-Tanda, A.; Gomez-Romero, L.; Alcaraz, N.; de Anda-Jauregui, G.; Penaloza, F.; Moreno, B.; Escobar-Arrazola, M. A.; Ramirez-Vega, O. A.; Cisneros-Villanueva, M.; Moreno-Camacho, J. L.; Rodriguez-Gallegos, J.; Luna-Ruiz Esparza, M. A.; Fernandez-Rojas, M. A.; Mendoza-Vargas, A.; Reyes-Grajeda, J. P.; Campos-Romero, A.; Angulo, O.; Ruiz, R.; Sheinbaum-Pardo, C.; Sifuentes-Osornio, J.; Kershenobich, D.; Hidalgo-Miranda, A.; Herrera, L. A.
title: The evolutionary landscape of SARS-CoV-2 variant B.1.1.519 and its clinical impact in Mexico City
date: 2021-09-14
journal: nan
DOI: 10.1101/2021.09.07.21262911
sha: 40176fb066e2cb1a8171cdcb4f6bca80a4d43eae
doc_id: 287581
cord_uid: 32lrk28s

The SARS-CoV-2 pandemic is one of the most concerning health problems around the globe. We report the emergence of SARS-CoV-2 variant B.1.1.519 in Mexico City. This variant represented up to 90% of sequenced cases in February 2021. It is characterized by three amino acid changes in the spike protein: T478K, P681H, and T732A. We report the effective reproduction number of B.1.1.519 and present evidence of its geographical origin based on phylogenetic analysis. We also studied its evolution via haplotype analysis and identified the most recurrent haplotypes. Finally, we studied the clinical impact of B.1.1.519: patients infected with variant B.1.1.519 showed a highly significant adjusted odds ratio (aOR) increase of 1.85 over non-B.1.1.519 patients for developing a severe/critical outcome (P = 0.000296, 1.33-2.6 95% CI) and a 2.35-fold increase for hospitalization (P = 0.005, 1.32-4.34 95% CI). The continuous monitoring of this and other variants will be required to control the ongoing pandemic as it evolves.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological cause of Coronavirus Disease 19 , and it has caused the largest and most severe pandemic of this century 1 .

Since December 2019, scientists around the world have generated 2.32 M whole-genome sequences of SARS-CoV-2 that have been made publicly available in the Global Initiative on Sharing all Influenza Data (GISAID) initiative database 2 . This massive genome sequencing effort has had an impact on public health and the handling of the pandemic, since it has allowed the design and updating of molecular tests for viral detection 3, 4 and guided the design of vaccines and antiviral treatments 5, 6 . Moreover, it has enabled the study of viral evolution, with in-depth investigation into the emergence and pursuit of variants of concern (VOCs), such as Alpha, Beta, Gamma, and Delta, and variants of interest (VOIs), such as Eta, Lambda, Iota and Kappa 7 .

Monitoring the emergence of new variants of SARS-CoV-2 is a worldwide priority, as alterations such as amino acid substitutions in the viral genome could be related to alterations in biological properties, such as the ligand-like affinity receptor, the neutralization efficiency resulting from naturally acquired immunity or vaccination [8] [9] [10] , or the transmission capacity 11 , as well as the impact on the clinical presentation of the disease 12 .

In Mexico, SARS-CoV-2 variants have been monitored since March 2020. During the third epidemic peak between February and March 2021, we observed an increase in variant . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Participants. Nasopharyngeal swabs (NPSs) were collected from 1,835 patients for SARS-CoV-2 detection. The study was approved by the ethics and research committees of the Instituto Nacional de Medicina Genómica (CEI/1479/20 and CEI 2020/21).

Sample collection. NPSs were collected by a trained clinician with a flexible nylon swab that was inserted into the patient's nostrils to reach the posterior nasopharynx. It was left in place for several seconds and slowly removed while rotating. The swab was then placed in 3 mL of sterile viral transport medium. Swabs from both nostrils were deposited in a single viral transport tube, taken to a clinical laboratory and processed immediately.

SARS-CoV-2 RNA extraction. Total nucleic acid was extracted from 300 μL of viral transport medium from the NPSs or 300 μL of whole saliva using the MagMAX Viral/Pathogen Nucleic Acid Isolation Kit (Thermo Fisher Scientific) and eluted into 75 μL of elution buffer.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 14, 2021. ;  https://doi.org/10.1101/2021.09.07.21262911 doi: medRxiv preprint 5 RT-qPCR. For SARS-CoV-2 RNA detection, 5 μL of RNA template was tested using the US CDC real-time RT-qPCR primer/probe sets for 2019-nCoV_N1 and 2019-nCoV_N2 and human RNase P (RP) as an extraction control. Samples were classified as positive for SARS-CoV-2 when both the N1 and N2 primer/probe sets were detected with a Ct value lower than 40 (Centers for Disease Control and Prevention, 2020). If only one of these genes was detected, the sample was labeled inconclusive. Also, RT-PCR was performed using the DA-930-Detection Kit for 2019 Novel Coronavirus (2019-nCoV) RNA (PCR-Fluorescence Probing) (DaAn Gene Co., Ltd. Of Sun Yat-sen University, Guangzhou, China) following the manufacturer´s instructions. All tests were run on Thermo Fisher ABI QuantStudio 5 or QuantStudio 7 real-time thermal cyclers. Samples were selected for inclusion in this study based on viral Ct <30.

Oxford Nanopore-Sequencing. We performed PCR tiling of the COVID-19 virus, version PTC_9096_v109_revF_06Feb2020. For nanopore amplicon sequencing of SARS-CoV-2, the ARTIC v3 amplification products of each sample were mixed and purified by using Agencourt AMPure XP beads at a 1:1 ratio and finally diluted in 30 μL of water. One microliter of purified DNA amplicons was used for quantification by Qubit (Qubit™ dsDNA HS Assay Kit). Sequencing library preparation consisted of two steps: native barcode ligation and sequencing adapter ligation. Native barcoding of amplicons was performed in a 20 μL reaction volume (1.5 μL DNA amplicons, 5 ng, 5.5 μL nuclease-free water, 2.5 of Native Barcode EXP-NBD104 and EXP-NBD114, 10 μL NEBNext Ultra II Ligation . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Oxford-Nanopore raw data processing and sequencing data quality assessment.

Basecalling and barcode demultiplexing were performed with guppy (v.4.4.1). Reads were processed according to the ARTIC Network protocols for COVID-19 13 using a nextflow pipeline (https://github.com/connor-lab/ncov2019-artic-nf). Briefly, for each sample, raw reads were mapped to the Wuhan reference sequence MN908947.3 using primer scheme V3 and Minimap (v.2.17). Post-alignment processing consisted of assigning reads to their derived amplicon and read group based on the primer pool, removing primer sequences, normalizing/reducing the number of read alignments to each amplicon and removing reads with imperfect pairings. Variant calling was performed with medaka (v.1.0.3) on the filtered and trimmed bam files. A final consensus FASTA file was generated by first marking positions not covered by at least 20 reads from either group as low coverage and building a pre-consensus FASTA with BCFtools consensus, which was subsequently aligned against the reference sequence using muscle (v.3.8.1551).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Only high-quality sequences were considered. SARS-CoV-2 reference genome NC_045512.2 was downloaded from NCBI. SNVs and indels per SARS-CoV-2 sequence were obtained with nucmer 16 . Nucmer was executed with the following parameters: map each position of each query to its best hit in the reference, map each position of each reference to its best hit in the query and exclude alignments with ambiguous mapping.

Variable positions in any SARS-CoV-2 sequence were obtained. Only variable positions observed in at least 5 genomes were further considered. Each SARS-CoV-2 sequence was translated into a compressed representation in which only the genotype of the list of variable positions was included. A unique combination of alleles, e.g., a unique compressed representation, was considered a haplotype. Haplotypes were used to infer a haplotype network using the haploNet function from the Population and Evolutionary Genetics Analysis System package (pegas) 17 . Briefly, genetic distances (Hamming distance) between all pairwise combinations of haplotypes were calculated using the dist.dna function of the Analyses of Phylogenetics and Evolution package (ape) 18 ; from this distance matrix, the minimum spanning tree and the median-joining network were computed using pegas 19 .

The sequences were aligned with MAFFT (version 7.475) using the FFT-NS-2 algorithm 20,21 . A maximum-likelihood phylogeny was calculated with FastTree (version . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint 

To gather and correlate clinical data from our patients, we used the National Epidemiologic Surveillance System for Viral Respiratory Diseases (SISVER). This system gathers information including personal identification data, contact information, comorbidities, date of diagnosis, symptoms, progression, and outcome of all the COVID-19 cases reported in Mexico. After downloading the data collected in this system, we verified and complemented this information with our own variants of interest by applying a telephone survey.

Verbal consent and identification were the first steps when calling each subject included in the final analysis. Questions on our survey covered comorbidities (diabetes, hypertension, cardiovascular diseases, chronic renal failure, COPD, asthma, HIV, cancer, obesity, smoking, pregnancy status and immunosuppression), date of symptom onset, sampling date, COVID-19 symptoms (fever, NSAID-resistant fever, cough, dyspnea, chest pain, oxygen saturation, headache, myalgias, arthralgias, odynophagia, anosmia, ageusia, diarrhea, vomiting, rhinorrhea, polypnea, cyanosis, conjunctivitis and abdominal pain), disease progression (ambulatory or hospitalized). In cases of hospitalized patients, we asked the length of hospital stay, treatment (need for supplementary oxygen or intubation) and outcome (alive, dead or under treatment). For underage or deceased . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 14, 2021. ; https://doi.org/10.1101/2021.09.07.21262911 doi: medRxiv preprint 11 patients, we tried to reach a close relative who was taking care of the individual and could answer all the questions with certainty.

Binary multivariate logistic regression models were fitted to predict the association of symptoms with variant B.1.1.519, as well as the association of hospitalization with the variant. An ordinal multivariate logistic regression model was fitted to predict the association of disease severity with the variant. The severity score was coded as 0 for asymptomatic or mild symptoms, 1 for severe symptoms and 2 for death. Individuals classified with severe disease were those who presented with at least one of the following: dyspnea, polypnea, cyanosis, requiring supplemental oxygen or intubation. All models were adjusted for covariates (age and sex) and comorbidities (immunosuppression, heart disease or hypertension, diabetes, obesity, asthma or smoking).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure 1D .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Phylogenetic analysis . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The prevalence of any haplotype was defined as the period of time (measured as the number of days) in which a haplotype was observed. The prevalence was defined as zero if a haplotype was observed in only one sample. The month of appearance corresponds to the month in which the first sequence of any specific haplotype was observed.

In Figure 3 , the most ancient B.1.1.519 sequence can be observed as a blue-bordered node. This node can be used as an anchor to suggest the temporal direction of the haplotype network. In this representation, the size of a node is proportional to the prevalence of the haplotype. The two most ancient nodes present two contrasting behaviors. One of them (red-bordered small node) was observed in very few samples The results show that haplotype III diverged in the three next-largest nodes, which implies that these three haplotypes are the next-most commonly observed haplotypes (70, 68 and 62 samples, respectively). All of these secondary haplotypes showed persistent behavior across time (166, 167, and 139 days of prevalence, respectively). Interestingly, all of these haplotypes diverged into a large number of less efficient virus variants.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Additionally, the month of appearance was consistent with the peak in the effective reproductive number described earlier, as most haplotypes were first observed in November and some in December 2020. Genomic surveillance has proven to be an important tool for the identification and characterization of viral spreading potential and the monitoring of novel variants of concern in SARS-CoV-2 11 . Based on genomic surveillance, we observed that variant . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. shown that the Delta VOC is associated with an increased risk of hospitalization and severe illness/disease compared to infections with non-Delta variants that circulate at the same time. This increase, although smaller, is still significant compared to infections involving the Alpha, Beta and Gamma VOCs. Similarly, the Gamma VOC has also shown . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 14, 2021. ;  an increased risk of hospitalization 53 and severity in young adults with pre-existing conditions 54 . There is little evidence relating the Beta VOC to more severe disease or death, with only one study 55 comparing differences in the first and second waves in South Africa as a "proxy" for the Beta variant, showing higher in-hospital mortality.

Sustained genomic surveillance plays a decisive role in identifying newly emerging SARS-CoV-2 variants and guiding the decisions of the public health care system in a country. Detailed evolutionary analysis is important to understand the origin and progression of newly evolving variants. Any significant clinical associations could be of interest in pandemic handling and containment.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 14, 2021. ; https://doi.org/10.1101/2021.09.07.21262911 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 14, 2021. ; https://doi.org/10.1101/2021.09.07.21262911 doi: medRxiv preprint (green) and USA (gray). The bootstrap value of the mixed cluster (described in the main text) is shown.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. April or May). Node size is proportional to the number of samples for that specific haplotype, and border width is proportional to the prevalence of the haplotype. Numbers correspond to the number of samples for that specific haplotype. The blue-bordered node indicates the haplotype with the most ancient appearance date for lineage B.1.1.519.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 14, 2021. ; https://doi.org/10.1101/2021.09.07.21262911 doi: medRxiv preprint

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Data, disease and diplomacy: GISAID's innovative contribution to global health: Data, Disease and Diplomacy

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy

Therapeutic Development and Drugs for the Treatment of COVID-19

World Health Organization. Tracking SARS-CoV-2 variants

Neutralization of variant under investigation B.1.617 with sera of

Estimated transmissibility and impact of SARS-CoV-2 lineage B

& Will Rowe. nCoV-2019 novel coronavirus bioinformatics protocol

A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics

Serial interval of novel coronavirus (COVID-19) infections

Versatile and open software for comparing large genomes

pegas: an R package for population genetics with an integrated-modular approach

ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R

Analysis of haplotype networks: The randomized minimum spanning tree method

MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform